Humans have several ways of keeping cancer at bay, and the p53 protein forms a crucial part of this self-defence. The newly discovered action of a p53-binding protein helps explain how cells respond to p53.
This is a preview of subscription content, log in via an institution to check access.
References
Vogelstein, B., Lane, D. & Levine, A. J. Nature 408, 307–310 (2000).
Brent Derry, W., Putzke, A. P. & Rothman, J. H. Science 294, 591–595 (2001).
Samuels-Lev, Y. et al. Mol. Cell 8, 781–794 (2001).
Iwabuchi, K., Bartel, P. L., Li, B., Marraccino, R. & Fields, S. Proc. Natl Acad. Sci. USA 91, 6098–6102 (1994).
Gorina, S. & Pavletich, N. P. Science 274, 1001–1005 (1996).
Iwabuchi, K. et al. J. Biol. Chem. 273, 26061–26068 (1998).
Chen, X. et al. Genes Dev. 10, 2438–2451 (1996).
Smart, P. et al. Oncogene 18, 7378–7386 (1999).
Saller, E. et al. EMBO J. 18, 4424–4437 (1999).
Ludwig, R. T. et al. Mol. Cell. Biol. 16, 4952–4960 (1996).
Polyak, K. Genes Dev. 10, 1945–1952 (1996).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lane, D. How cells choose to die. Nature 414, 25–27 (2001). https://doi.org/10.1038/35102132
Issue Date:
DOI: https://doi.org/10.1038/35102132
- Springer Nature Limited
This article is cited by
-
Expression pattern of the apoptosis-stimulating protein of p53 family in p53+ human breast cancer cell lines
Cancer Cell International (2013)
-
Visualization and targeted disruption of protein interactions in living cells
Nature Communications (2013)
-
Peptide, Peptidomimetic, and Small-molecule Antagonists of the p53–HDM2 Protein–Protein Interaction
International Journal of Peptide Research and Therapeutics (2006)
-
Abnormal mRNA expression of ASPP members in leukemia cell lines
Leukemia (2004)
-
Myc suppression of the p21Cip1 Cdk inhibitor influences the outcome of the p53 response to DNA damage
Nature (2002)